Kiromic BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
For the nine months, net loss was USD 16.26 million compared to USD 27.66 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.76 USD | +3.37% | +8.24% | +217.24% |
05-10 | Kiromic BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-01 | Kiromic BioPharma, Inc. announced that it has received $2 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
+217.24% | 3.56M | |
+7.52% | 113B | |
+11.38% | 106B | |
-12.64% | 22.22B | |
+0.26% | 22.27B | |
-3.71% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+37.41% | 12.52B | |
-23.95% | 8.34B |